Search
for
Sort by
Research 181–210 of 508
- In silico structural prediction of human steroid 5α-reductase type II
- Steroid Hormones
- Evaluation of bioequivalence of five 0.1 mg dutasteride capsules compared to one 0.5 mg dutasteride capsule: a randomized study in healthy male volunteers
- Regarding prostate-specific antigen: let's not shoot the messenger
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- Randomized Placebo-Controlled Clinical Trial of Dutasteride for Reducing Heavy Drinking in Men
- Effect of dose reduction of dutasteride in combination with alpha-blockers in patients with lower urinary tract symptoms/benign prostatic enlargement
- Three-Dimensional Analysis of Sex- and Gonadal Status- Dependent Microglial Activation in a Mouse Model of Parkinson’s Disease
- Dutasteride intralesional microinjections in combination with oral minoxidil vs. oral minoxidil monotherapy in men with androgenetic alopecia: a retrospective analysis of 105 patients
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Cerebral Venous Sinus Thrombosis Associated with Dutasteride Use
- Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men
- Effects of 5-alpha reductase inhibitors
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Contraindicated use of 5-alpha-reductase inhibitors in women
- This Week in JAMA
- Primärprävention urologischer Tumore: Prostatakarzinom
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Finasteride versus dutasteride: a real-world economic evaluation.
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Body mass index as a potential confounder in dutasteride and fertility studies
- The comparative effectiveness of prescription and selected alternative therapies for pattern hair loss: protocol for a multiple treatment comparison meta-analysis
- Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis
- Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial
- Oral dutasteride is a first‐line treatment for frontal fibrosing alopecia
- THU372 Finasteride Induced Hyperglycemia
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Dutasteride nanoemulsion preparation to inhibit 5-alpha-hair follicle reductase enzymes in the hair follicle; an ex vivo study.
- Androgens and Parkinson’s disease: the role in humans and in experiment